Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SNRPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KDELR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC61B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CADM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PALD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDELR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCAI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARP4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDV3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CGN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTPBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2AM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3C2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ME2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on